ResMed, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US7611521078
USD
230.84
-1.57 (-0.68%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
1,422.81
1,335.58
1,347.99
1,291.74
1,282.09
1,224.51
1,223.19
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,422.81
1,335.58
1,347.99
1,291.74
1,282.09
1,224.51
1,223.19
Raw Material Cost
555.85
526.72
539.85
536.22
541.86
518.69
518.93
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
3.18
4.79
5.50
9.55
Selling and Distribution Expenses
275.70
259.19
265.12
245.30
241.61
238.98
242.19
Other Expenses
9.10
8.73
8.64
8.08
7.66
7.40
7.13
Total Expenditure (Excl Depreciation)
922.51
873.23
891.42
865.47
864.85
837.20
841.98
Operating Profit (PBDIT) excl Other Income
500.3
462.29999999999995
456.59999999999997
426.3
417.2
387.29999999999995
381.2
Other Income
4.95
-1.61
-0.44
-5.25
1.43
0.29
-14.68
Operating Profit (PBDIT)
567.58
518.40
530.42
472.93
474.57
441.32
421.29
Interest
0.00
0.00
0.00
3.18
4.79
5.50
9.55
Exceptional Items
-9.10
-13.94
1.92
-0.15
4.44
1.39
0.75
Gross Profit (PBDT)
866.96
808.86
808.14
755.51
740.23
705.82
704.26
Depreciation
62.33
57.67
74.29
51.91
55.90
53.71
54.75
Profit Before Tax
496.15
446.79
458.05
417.69
418.32
383.50
357.73
Tax
103.56
98.26
78.35
52.65
73.70
72.14
65.50
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
392.59
348.54
379.70
365.04
344.62
311.36
292.24
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
392.59
348.54
379.70
365.04
344.62
311.36
292.24
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
392.59
348.54
379.70
365.04
344.62
311.36
292.24
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
6,320.88
6,121.26
5,967.86
5,546.13
5,253.01
5,195.03
4,864.04
Earnings per share (EPS)
2.68
2.37
2.58
2.48
2.34
2.11
1.98
Diluted Earnings per share
2.68
2.37
2.58
2.48
2.34
2.11
1.98
Operating Profit Margin (Excl OI)
35.16%
34.62%
33.87%
33.0%
32.54%
31.63%
31.17%
Gross Profit Margin
39.25%
37.77%
39.49%
36.35%
36.99%
35.7%
33.72%
PAT Margin
27.59%
26.1%
28.17%
28.26%
26.88%
25.43%
23.89%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 10.97% vs 10.26% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 13.93% vs 65.04% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 18.92% vs 20.47% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is -100.00% vs -65.22% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Compare Quarterly Results Of ResMed, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
1,422.81
1,047.56
375.25
35.82%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,422.81
1,047.56
375.25
35.82%
Raw Material Cost
555.85
370.52
185.33
50.02%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
275.70
441.68
-165.98
-37.58%
Other Expenses
9.10
8.30
0.80
9.64%
Total Expenditure (Excl Depreciation)
922.51
895.23
27.28
3.05%
Operating Profit (PBDIT) excl Other Income
500.30
152.33
347.97
228.43%
Other Income
4.95
20.17
-15.22
-75.46%
Operating Profit (PBDIT)
567.58
281.74
285.84
101.46%
Interest
0.00
0.00
0.00
Exceptional Items
-9.10
-3.17
-5.93
-187.07%
Gross Profit (PBDT)
866.96
677.04
189.92
28.05%
Depreciation
62.33
101.98
-39.65
-38.88%
Profit Before Tax
496.15
176.59
319.56
180.96%
Tax
103.56
40.84
62.72
153.57%
Provisions and contingencies
0
0
0.00
Profit After Tax
392.59
135.76
256.83
189.18%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
392.59
135.76
256.83
189.18%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
392.59
135.76
256.83
189.18%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
6,320.88
4,049.15
2,271.73
56.10%
Earnings per share (EPS)
2.68
1.89
0.79
41.80%
Diluted Earnings per share
2.68
1.89
0.79
41.80%
Operating Profit Margin (Excl OI)
35.16%
15.23%
0.00
19.93%
Gross Profit Margin
39.25%
26.59%
0.00
12.66%
PAT Margin
27.59%
12.96%
0.00
14.63%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 142.28 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 6.53% vs -0.92% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 10.97% vs 10.26% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 39.26 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 12.65% vs -8.22% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 13.93% vs 65.04% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 56.26 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 8.19% vs -2.05% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 18.92% vs 20.47% in Dec 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 35.16%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024